BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22417308)

  • 1. Xeroderma pigmentosum complementation group G patient with a novel homozygous missense mutation and no neurological abnormalities.
    Moriwaki S; Takigawa M; Igarashi N; Nagai Y; Amano H; Ishikawa O; Khan SG; Kraemer KH
    Exp Dermatol; 2012 Apr; 21(4):304-7. PubMed ID: 22417308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of three XPG-defective patients identifies three missense mutations that impair repair and transcription.
    Schäfer A; Schubert S; Gratchev A; Seebode C; Apel A; Laspe P; Hofmann L; Ohlenbusch A; Mori T; Kobayashi N; Schürer A; Schön MP; Emmert S
    J Invest Dermatol; 2013 Jul; 133(7):1841-9. PubMed ID: 23370536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of neurologic degeneration to genotype in three xeroderma pigmentosum group G patients.
    Emmert S; Slor H; Busch DB; Batko S; Albert RB; Coleman D; Khan SG; Abu-Libdeh B; DiGiovanna JJ; Cunningham BB; Lee MM; Crollick J; Inui H; Ueda T; Hedayati M; Grossman L; Shahlavi T; Cleaver JE; Kraemer KH
    J Invest Dermatol; 2002 Jun; 118(6):972-82. PubMed ID: 12060391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel XPG (ERCC5) mutations affect DNA repair and cell survival after ultraviolet but not oxidative stress.
    Soltys DT; Rocha CR; Lerner LK; de Souza TA; Munford V; Cabral F; Nardo T; Stefanini M; Sarasin A; Cabral-Neto JB; Menck CF
    Hum Mutat; 2013 Mar; 34(3):481-9. PubMed ID: 23255472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and molecular epidemiological study of xeroderma pigmentosum in China: A case series of 19 patients.
    Zhou EY; Wang H; Lin Z; Xu G; Ma Z; Zhao J; Feng C; Duo L; Yin J; Yang Y
    J Dermatol; 2017 Jan; 44(1):71-75. PubMed ID: 27607234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mutation in the XPA gene associated with unusually mild clinical features in a patient who developed a spindle cell melanoma.
    Sidwell RU; Sandison A; Wing J; Fawcett HD; Seet JE; Fisher C; Nardo T; Stefanini M; Lehmann AR; Cream JJ
    Br J Dermatol; 2006 Jul; 155(1):81-8. PubMed ID: 16792756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological symptoms and natural course of xeroderma pigmentosum.
    Anttinen A; Koulu L; Nikoskelainen E; Portin R; Kurki T; Erkinjuntti M; Jaspers NG; Raams A; Green MH; Lehmann AR; Wing JF; Arlett CF; Marttila RJ
    Brain; 2008 Aug; 131(Pt 8):1979-89. PubMed ID: 18567921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations that disable the DNA repair gene XPG in a xeroderma pigmentosum group G patient.
    Nouspikel T; Clarkson SG
    Hum Mol Genet; 1994 Jun; 3(6):963-7. PubMed ID: 7951246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The founding members of xeroderma pigmentosum group G produce XPG protein with severely impaired endonuclease activity.
    Lalle P; Nouspikel T; Constantinou A; Thorel F; Clarkson SG
    J Invest Dermatol; 2002 Feb; 118(2):344-51. PubMed ID: 11841555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strict sun protection results in minimal skin changes in a patient with xeroderma pigmentosum and a novel c.2009delG mutation in XPD (ERCC2).
    Emmert S; Ueda T; Zumsteg U; Weber P; Khan SG; Oh KS; Boyle J; Laspe P; Zachmann K; Boeckmann L; Kuschal C; Bircher A; Kraemer KH
    Exp Dermatol; 2009 Jan; 18(1):64-8. PubMed ID: 18637129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of Transcription Elongation by the XPG-TFIIH Complex Is Implicated in Cockayne Syndrome.
    Narita T; Narita K; Takedachi A; Saijo M; Tanaka K
    Mol Cell Biol; 2015 Sep; 35(18):3178-88. PubMed ID: 26149386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
    Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F
    J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complementation of transformed fibroblasts from patients with combined xeroderma pigmentosum-Cockayne syndrome.
    Ellison AR; Nouspikel T; Jaspers NG; Clarkson SG; Gruenert DC
    Exp Cell Res; 1998 Aug; 243(1):22-8. PubMed ID: 9716445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human XPG nuclease structure, assembly, and activities with insights for neurodegeneration and cancer from pathogenic mutations.
    Tsutakawa SE; Sarker AH; Ng C; Arvai AS; Shin DS; Shih B; Jiang S; Thwin AC; Tsai MS; Willcox A; Her MZ; Trego KS; Raetz AG; Rosenberg D; Bacolla A; Hammel M; Griffith JD; Cooper PK; Tainer JA
    Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14127-14138. PubMed ID: 32522879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A common mutational pattern in Cockayne syndrome patients from xeroderma pigmentosum group G: implications for a second XPG function.
    Nouspikel T; Lalle P; Leadon SA; Cooper PK; Clarkson SG
    Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3116-21. PubMed ID: 9096355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion of the genotypic and phenotypic spectrum of xeroderma pigmentosum in Chinese population.
    Zhang J; Cheng R; Yu X; Sun Z; Li M; Yao Z
    Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):58-63. PubMed ID: 27982466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Xeroderma pigmentosum group G with severe neurological involvement and features of Cockayne syndrome in infancy.
    Zafeiriou DI; Thorel F; Andreou A; Kleijer WJ; Raams A; Garritsen VH; Gombakis N; Jaspers NG; Clarkson SG
    Pediatr Res; 2001 Mar; 49(3):407-12. PubMed ID: 11228268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of UV-induced apoptosis by the human DNA repair protein XPG.
    Clément V; Dunand-Sauthier I; Clarkson SG
    Cell Death Differ; 2006 Mar; 13(3):478-88. PubMed ID: 16167068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 10-year follow-up of a child with mild case of xeroderma pigmentosum complementation group D diagnosed by whole-genome sequencing.
    Ono R; Masaki T; Mayca Pozo F; Nakazawa Y; Swagemakers SM; Nakano E; Sakai W; Takeuchi S; Kanda F; Ogi T; van der Spek PJ; Sugasawa K; Nishigori C
    Photodermatol Photoimmunol Photomed; 2016 Jul; 32(4):174-80. PubMed ID: 26993158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pellagra-like condition is xeroderma pigmentosum/Cockayne syndrome complex and niacin confers clinical benefit.
    Hijazi H; Salih MA; Hamad MH; Hassan HH; Salih SB; Mohamed KA; Mukhtar MM; Karrar ZA; Ansari S; Ibrahim N; Alkuraya FS
    Clin Genet; 2015; 87(1):56-61. PubMed ID: 24354460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.